Sign up to save your podcasts
Or
Share BetaCell Podcast
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
BetaCell Podcast
By Beta Cells in DiabetesMedicine
BetaCell Podcast episodes
- The Diabetes Control and Complications Trial: Weight EffectsDr. Doron Schneider and Dr. Jack Leahy discuss what The Diabetes Control and Complications discovered about weight issues and the Diabetic patient.0 min
- DCCT and EDIC: Implications for Type 2 DiabetesDr. Doron Schneider and Dr. Jack Leahy discuss what the DCCT and EDIC trials found regarding type 2 diabetes.0 min
- DCCT, EDIC, and “Metabolic Memory”Dr. Schneider and Dr. Leahy discuss the surprising result of "metabolic memory" from the findings of the DCCT and EDIC trials.0 min
- DCCT and EDIC: Impact of Tight Control on HypoglycemiaDr. Schneider and Dr. Leahy, discuss the findings of the DCCT and EDIC studies as they relate to the impact of tight control of diabetes in the early stages of the disease.0 min
- EDIC: Follow-Up Findings To The Diabetes Control and Complications TrialDr. Schneider and Dr. Leahy discuss EDIC, the follow up study to The Diabetes Control and Complications trial.0 min
- History of The Diabetes Control and Complications Trial (DCCT)Dr. Doron Schneider and Dr. Jack Leahy discuss The Diabetes and Complications Trial, a landmark study that still influences the standard of diabetes patient care.0 min
- DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up StudyDr. Doron Schneider and Dr. Jack Leahy discuss the Diabetes Control and Complications Trial and the follow up study, EDIC. These landmark, studies performed 30 years ago, have stood the test of time and still influences the standard of care today.0 min
- The Case for Bariatric Surgery as an Initial Treatment OptionDoron Schneider, MD and Jack Leahy, MD discuss the effectiveness and challenges of bariatric surgery. (7:18)0 min
- Considering CAD Risk Factors in Treatment DecisionsDoron Schneider, MD and Jack Leahy, MD discuss the importance of patient BMI and other risk factors for coronary artery disease when weighing treatment options. (12:08)0 min
- Initial Combination Therapy in a Newly Diagnosed T2DM PatientDoron Schneider, MD and Jack Leahy, MD discuss the pros and cons of combination therapy for as initial treatment. (17:40)0 min
About BetaCell Podcast
From the publisher's feed
The Beta Cells in Diabetes podcast seeks to improve understanding among primary care physicians about the role of beta cells as key drivers in the development and progression of T2DM. Our goal is to…
engage primary care physicians in pathopysiology-based clinical decision making through an interactive educational format that stimulates debate and encourages physicians to incorporate the new science into their patient treatment regimens. By educating primary care physicians about the newest findings regarding beta cell treatment, we hope to positively affect the diabetes epidemic.